<unk>  is indicated as an adjunct to diet in people with primary non-familial hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C); and alone or as an adjunct to other LDL-C-lowering therapies in people with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C.
Ezetimibe/rosuvastatin
Ezetimibe/atorvastatin
Ezetimibe/simvastatin
Bempedoic acid/ezetimibe
Fenofibrate/pravastatin
Fenofibrate/simvastatin
Amlodipine/atorvastatin
Dapagliflozin/saxagliptin/metformin